Skip to main content
Clinical Trials/NL-OMON33052
NL-OMON33052
Completed
Phase 2

Pilot study of the feasibility of research on the application of bright light as a means of restoring the sleep-wake rhythm in patients with schizophrenia admitted to the locked ward, and by that means alleviating their psychotic symptoms. - Light Therapy in Schizophrenia

Parnassia (Den Haag)0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
disturbed circadian rhythm in schizophrenia
Sponsor
Parnassia (Den Haag)
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Parnassia (Den Haag)

Eligibility Criteria

Inclusion Criteria

  • \- All patients diagnosed with schizophrenia or schizoaffective disorder by a psychiatrist according to the DSM\-IV TR classification.
  • \- Patients who are admitted to the clinical institution KCVG.
  • \- Patients for whom informed consent and informed consent by proxy has been given.

Exclusion Criteria

  • \- Patients with diagnosis of bipolar disorder.
  • \- Patients with a current manic episode measured with the Young Mania Rating Scale.
  • \- Patients with contra\-indications for light therapy after eye examination, such as glaucoma, retinopathy or cataracts.
  • \- Patients with epilepsy in history or at present

Outcomes

Primary Outcomes

Not specified

Similar Trials